For those interested, the podcast linked below, The Importance of Collaboration Between Academia and the Biotech Industry, has an interview with Prof. Sue Fletcher and talks about her work with PYC.
Although dated 20 September 2023, it seems to have been recorded some time earlier.
Sue Fletcher has recently retired as CSO at PYC and now sits on the PYC Scientific Advisory Board. She has also retired from her position as Senior Principal Research Fellow at Murdoch University. Sue is said to be continuing to work with collaborators, and her team at Murdoch University, to develop antisense therapeutics for rare diseases, with a focus on motor neuron disease.
https://www.thermofisher.com/blog/b...on-between-academia-and-the-biotech-industry/
https://www.mq.edu.au/research/rese...motor-neuron-disease-research/conference-2023
Ann: Q3 Investor Call Presentation, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $6.07K | 60.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1836604 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 1053833 | 7 |
View Market Depth
| Last trade - 13.20pm 30/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |